Xoft Executive Management Team
Ken Ferry - Chief Executive Officer
As Chief Executive Officer of iCAD, Kenneth M. Ferry brings two decades of extensive experience in the management and leadership of healthcare technology organizations, with more than a decade of direct responsibility to the organizations’ P&L.
Mr. Ferry’s previous experience has clearly demonstrated his ability to lead unprecedented growth. He was most recently Senior Vice President and General Manager for the Global Patient Monitoring business for Philips Medical Systems, the market leader in a $2.5 billion industry. In this role he was responsible for Research & Development, Marketing, Business Development, Supply Chain and Manufacturing, Quality and Regulatory, Finance and Human Resources. Mr. Ferry was named a Senior Vice President at Philips Medical Systems Division in 2001.
From 1983 to 2001, Mr. Ferry served in a number of management positions with Hewlett Packard and Agilent Technologies. As a Vice President and General Manager in the Hewlett Packard / Agilent Technologies Healthcare Solutions Group, he was one of the key executives responsible for the sale of Agilent’s Medical Solutions Group to Philips in August 2001. Prior to this, beginning in 1997, he served as Vice President and General Manager of North American Field Operations for Hewlett Packard and Agilent Technologies. He was responsible for sales, service, and marketing for Patient Monitoring, Cardiac Ultrasound, Defibrillation, Diagnostic EKG and Information Technology solutions.
In addition to his role as Chief Executive Officer, Ferry also serves as a member of iCAD’s Board of Directors. Ferry is a graduate of the Boston College, School of Management, in Chestnut Hill, Massachusetts.
Richard Christopher – Executive Vice President, Chief Financial Officer
Richard Christopher holds the positions of Executive Vice President and Chief Financial Officer for iCAD. In his most recent previous role, Mr. Christopher served as Chief Financial and Operating Officer of Caliber Imaging & Diagnostics, Inc. Prior to this, Mr. Christopher was Vice President, Finance and Chief Financial Officer of DUSA Pharmaceuticals, Inc., a NASDAQ-listed specialty dermatology company focused on the treatment of precancerous skin lesions. He joined DUSA in 2000 and held a series of positions of increasing responsibility, including serving as Chief Financial Officer from 2005 through its acquisition and integration into Sun Pharmaceuticals Industries Limited in 2013. He received a Master’s of Science Degree in Accounting from Suffolk University and a Bachelor’s of Science Degree in Finance from Bentley University.
Stacey Stevens - Executive Vice President, Chief Strategy and Commercial Officer
Stacey Stevens holds the position of Executive Vice president, Chief Strategy and Commercial Officer for iCAD. In previous roles she has served in a variety of sales, business development, and marketing management positions with Philips Medical Systems, Agilent Technologies and Hewlett Packard's Healthcare Solutions Group (which was acquired in 2001 by Philips Medical Systems). She most recently held the position of Vice President, Marketing Planning at Philips Medical Systems, where she was responsible for the leadership of all global marketing planning functions for Philips' Healthcare Business. From 2003 to 2005, she was Vice President of Marketing for the Cardiac and Monitoring Systems Business Unit of Philips where she was responsible for all marketing and certain direct sales activities for the America 's Field Operation. Prior to that, Stevens held several key marketing management positions in the Ultrasound Business Unit of Hewlett-Packard/Agilent and Philips Medical Systems.
Ms. Stevens earned a Bachelor of Arts Degree in Political Science from the University of New Hampshire, and an MBA from Boston University’s Graduate School of Management.
Kamal Gogineni - Senior Vice President & Chief Commercial Officer Oncology Solutions
Kamal Gogineni serves as Senior Vice President & Chief Commercial Officer Oncology Solutions at iCAD. Mr. Gogineni's experience and career spans more than 20 years, successfully building businesses that have delivered high value and accelerated growth in health care, software and engineering.
Prior to joining iCAD, Mr. Gogineni was the Founder and Chief Executive Officer of Radion, Inc. a healthcare software as a service (SaaS) company. Mr. Gogineni was an investor and founder of DermEbx, a healthcare solutions company that created an integrated network and a collaborative platform delivering oncology solutions to physician practices. Mr. Gogineni also founded Techquest in 1998, a workflow and infrastructure asset management software business that licensed large scale managed solutions to Fortune 500 companies.
Radion and DermEbx companies were successfully acquired by iCAD in July 2014.
Mr. Gogineni serves on various boards and committees in healthcare and related fields. He holds a B.S. in Mechanical Engineering and M.S. in Industrial Technology with specialization in CAD and Robotics.
All Xoft treatments must be performed with a thorough knowledge of radiation physics, proper planning, dosimetric calculations and knowledge of radio-biological effectiveness; therefore, we require that a radiation therapist/oncologist administer the use of the Xoft Electronic Brachytherapy (eBx) System. We do not support the use of the Xoft System by anyone other than radiation professionals (trained and certified). We rigorously enforce this, as patient safety and efficacy is preeminent to us.
©2017 Xoft®, a subsidiary of iCAD, Inc. All rights reserved. Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc.
Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.